Advice for Inquiring About Myeloma CAR T-Cell Therapy Clinical Trials
How can patients find CAR T-cell therapy clinical trials? Nurse practitioner Donna Catamero shares resources for identifying trials, such as ClinicalTrials.gov, and encourages patients to ask providers about available trials and eligibility.
Donna Catamero is a Nurse Practitioner and associate director of the Multiple Myeloma Clinical Research Program at Mount Sinai Hospital in New York City. Learn more about Donna Catamero.
Related Resources:
![]() |
![]() |
![]() How Can Myeloma Patients Access CAR T-Cell Therapy Clinical Trials? |
Transcript:
Katherine Banwell:
How can patients find CAR T clinical trials that might be right for them?
Donna Catamero:
So, ClinicalTrials.gov can point patients in the right direction. Again, the foundations – the Multiple Myeloma Research Foundation, the International Myeloma Foundation – can help direct patients toward clinical trials that might be right for them.
Katherine Banwell:
How can patients start the conversation with their provider? What questions should they be asking about trials?
Donna Catamero:
So, first, when you’re given options for treatment, you should always ask – always, always ask – “Am I eligible for a clinical trial?”
All the therapies we have available today for patients initially came from clinical trials. In our early CAR T therapies, those patients had access to those drugs years before the general myeloma population, so clinical trials are key to really moving the therapies for tomorrow.